In quiet debut, Alzheimer’s drug finds questions, skepticism
The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more
Read moreThe first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more
Read moreWe use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This
Read moreFox News Flash top headlines for July 1 Fox News Flash top headlines are here. Check out what’s clicking on
Read moreA growing trove of data to help scientists understand the biology of Alzheimer’s disease among diverse populations within the context
Read moreAlzheimer’s disease is the main cause of dementia and current therapeutic strategies cannot prevent, slow down or cure the pathology.
Read moreResearchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have
Read moreAlzheimer’s disease is known for its slow attack on neurons crucial to memory and cognition. But why are these particular
Read moreResearchers have used a genetic engineering strategy to dramatically reduce levels of tau—a key protein that accumulates and becomes tangled
Read moreWarning signs for Alzheimer’s disease (AD) can begin in the brain years before the first symptoms appear. Spotting these clues
Read moreEarly diagnosis of Alzheimer’s disease has been shown to reduce cost and improve patient outcomes, but current diagnostic approaches can
Read more